The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa

Movement Disorders

Volumn 15, Issue 5, 2000, Pages 862-868

  Reuter, I ^a   Harder, S ^b   Engelhardt, M ^b   Baas, H ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Dyskinesias; Levodopa; Parkinson's disease; Pharmacodynamics; Pharmacokinetics; Physical exercise

Indexed keywords

BENSERAZIDE; LEVODOPA;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; EXERCISE; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PHARMACODYNAMICS; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; REST; WORKLOAD;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CROSS-OVER STUDIES; DYSKINESIAS; EXERCISE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 0033809616     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200009)15:5<862::AID-MDS1015>3.0.CO;2-S     Document Type: Article

References (18)

1. Exercise and antiparkinsonian response to levodopa
2. The effect of exercise on levodopa absorption
3. Blood levodopa and Unified parkinson's disease rating scale function: With and without exercise
4. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
5. Qualitative assessment of Parkinson's disease: A study of reliability and data reduction with an abbreviated Columbia University rating scale
6. Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
7. Simple and rapid micro-method for the determination of levodopa and 3-O-methyldopa in human plasma by HPLC with colourimetric detection
8. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease
9. Understanding the dose effect relationship: Clinical application of pharmacokinetic pharmacodynamic models
10. The use of kinetic-dynamic interactions in the evaluation of drugs
11. Semiparametric approach to pharmacokinetic-pharmakodynamic data
12. Concentration-effect relationship of levodopa in patients with Parkinson's disease
13. Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulation
14. Longitudinal monitoring of the levodopa concentration effect relationship in Parkinson's disease
15. Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease
16. Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine
17. Concentration/effect relationship of levodopa alone and under apomorphine in patients with Parkinson's disease
18. A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease